Home NxThera

NxThera

acquired
Series C
Various Urinary System Disease Treatment Technology R&D Companies
Basic
Enterprise Profile

Basic Information

NXTERA has developed medical technology to treat various urinary system diseases, including benign prostatic hyperplasia (BPH). The company's technology platform utilizes a simple, minimally invasive steam therapy designed to significantly improve urine flow and patients' quality of life. In the United States, more than 32 million men suffer from BPH.
NxThera, Inc.
Minnesota,United States of America
101~500 people
January 01, 2008
info@nxthera.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Therapeutic Manufacturing
Technology
Gene Technology Biotechnology
Concept
Disease Treatment
Application Scenarios
Medical Device Consumables